Security key
036752103
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 204,337,175
- Total 13F value
- $106,108,060,305
- Share change
- -3,888,371
- Put/Call ratio
- 100%
- SEC-reported price per share
- $520.00
- Number of holders
- 1,677
- Value change
- -$2,056,527,998
- Number of buys
- 791
- Number of sells
- 719
- Shares outstanding
- 232,836,241
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
1,677
Top holders
10
ELV full security history
Ownership snapshot
Full 13F holder table
Elevance Health, Inc. SEC filings
Elevance Health, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $11,491,184,380
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $11.49B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$11.49B
BlackRock Finance, Inc.
$11.22B
PRICE T ROWE ASSOCIATES INC /MD/
$6.31B
STATE STREET CORP
$5.72B
GEODE CAPITAL MANAGEMENT, LLC
$2.57B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$11,491,184,380
21,206,925 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$11,219,056,885
20,704,715 shares
|
— | 30 Jun 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
denominator unverified
|
$6,310,788,000
11,646,526 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$5,721,114,478
10,558,289 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$2,573,092,803
4,762,250 shares
|
— | 30 Jun 2024 |
| Sanders Capital, LLC |
13F
Company
|
—
denominator unverified
|
$2,473,294,503
4,564,453 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,677
Shares
204,337,175
Rows available
1,677
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
1,694
Q3 2024 holders
1,677
Holder diff
-17
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|